Show an ad over header. AMP

I am the second

The drug pricing lawsuit that could blow up Medicare

A federal judge will soon determine whether Pfizer can pay Medicare patients' out-of-pocket expenses for one of its heart medications that is priced at $225,000 per year.

Why it matters: A ruling in Pfizer's favor would legalize something that is viewed as a kickback under current law, and would jeopardize taxpayer coffers by spurring a "gold rush" of pharmaceutical companies to cover Medicare copays for expensive drugs.

Keep reading...Show less

Related Articles



Get Goodhumans in your inbox

Most Read

More Stories